Effect of inflammation on molecular targets and drug transporters

Sherif Hanafy1, Ayman O S El-Kadi, Fakhreddin Jamali

  • 1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.

Insights

Inflammation significantly alters gene expression of drug transporters in rat organs, impacting drug disposition and potentially leading to therapeutic failure. This study highlights key changes in liver, kidney, and heart transporter expression during chronic inflammation.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Immunology

Background:

  • Inflammation, a biological response to infection or injury, alters the expression of various genes, including those involved in drug metabolism and transport.
  • Understanding these alterations is crucial for predicting drug efficacy and managing potential therapeutic failures in inflammatory conditions.

Purpose of the Study:

  • To investigate the impact of chronic inflammation on the gene expression of specific drug transporters and molecular targets.
  • To characterize how inflammation affects drug action and disposition by examining changes in transporter expression in key organs.

Main Methods:

  • Utilized a rat model of adjuvant arthritis (AA) to induce chronic inflammation.
  • Quantified the gene expression of numerous drug transporters and inflammatory markers in heart, liver, kidneys, and intestine using real-time polymerase chain reaction (RT-PCR).

Main Results:

  • Significant downregulation of organic anion transporting polypeptide 4a1 (oatp4a1), organic cation transporter 1 (oct1), and multidrug resistance-associated protein 1 (mrp1) gene expression was observed in the liver.
  • Kidney exhibited significant reductions in oatp2b1, mrp6, and bile salt export pump (bsep) gene expression.
  • Oatp4a1 and multidrug resistance 1a (mdr1a) gene expression were significantly upregulated in the rat heart.

Conclusions:

  • Chronic inflammation demonstrably alters the gene expression profiles of critical drug transporters in various organs.
  • These changes in transporter expression can significantly influence drug pharmacokinetics and pharmacodynamics.
  • The observed alterations may contribute to reduced drug efficacy and therapeutic failure in patients with inflammatory diseases.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Inflammation01:38

Inflammation

Overview
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...